Legacy Bridge’s Quest Diagnostics DGX Stock Holding History

Legacy Bridge’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$1.91K	–	367
2025 Q4	$1.91K	Buy	+11	New	+$2K	﹤0.01%	424

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Legacy Bridge's DGX Position: Q1 2026 in Review

Legacy Bridge sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 11 shares — an estimated $1.91K sold.

Legacy Bridge first reported a position in DGX in Q4 2025 and held it in 1 quarter. The position peaked at $1.91K in Q4 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Legacy Bridge reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Legacy Bridge sold 11 Quest Diagnostics shares in Q1 2026, an estimated $1.91K.
Legacy Bridge first reported a position in Quest Diagnostics in Q4 2025 and held it in 1 quarter.
Legacy Bridge's Quest Diagnostics position peaked at $1.91K in Q4 2025.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.